From: Richard Kahn
Sent: Thursday, August 13, 2015 9:03 PM
To: jeffrey E.
Subject: Avalanche Biotechnologies beats by $0.01, misses on revenue
Aug 13 2015, 16:45 ET I About: Avalanche Biotechnologies (AAVL) <http://seekingalpha.com/symbol/AAVL> I By: Mohit
Manghnani <http://seekingalpha.com/author/sa-editor-mohit-manghnani> , SA News Editor
<http://seekingalpha.com/images/mail_icon.png>
• Avalanche Biotechnologies (NASDAQ:AAVL <http://seekingalpha.com/symbol/aavl> ): Q2 EPS of -$0.38 beats by
$0.01.
Revenue of $0.2M (+42.9% Y/Y) misses by $0.56M.
* Shares -13.2%.
http://seekingalpha.com/pr/14409436-avalanche-biotechnologies-inc-reports-second-quarter-2015-financial-results-
and-provides-update-on-avaminus-101-program
Richard Kahn
HBRK Associates Inc.
575 Lexington Avenue 4th Floor
New York, NY 10022
tel 212-971-1306
fax 646-350-0954
cell 917-414-7584
1
EFTA_R1_01354253
EFTA02361909